Expert Review of Proteomics (ISSN 1478-9450) seeks to collect together technologies, methods and discoveries from the field of proteomics to advance scientific understanding of the many varied roles protein expression plays in human health and disease.
The journal coverage includes, but is not limited to, overviews of specific technological advances in the development of protein arrays, interaction maps, data archives and biological assays, performance of new technologies and prospects for future drug discovery. 
  
The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: 
  
Expert commentary - a personal view on the most effective or promising strategies 
Five-year view - a clear perspective of future prospects within a realistic timescale 
Key issues - an executive summary cutting to the author's most critical points

Rolf Apweiler, European Bioinformatics Institute, Cambridge, UK
Geert Baggerman, VITO (Flemish Institute for Technological Research), Belgium
Jonathan Blackburn, University of Cape Town, South Africa
Christoph Borchers, University of North Carolina, NC, USA 
Richard Burchmore, University of Glasgow, UK 
William Cho, Queen Elizabeth Hospital, Hong Kong
Jasminka Godovac Zimmermann, University College London, United Kingdom 
Seth Grant, University of Edinburgh, UK
Canhua Huang, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
Thomas Joos, University of Tuebingen, Germany 
Tadashi Kondo, National Cancer Center Research Institute, Japan 
Lydie Lane, wiss Institute of Bioinformatics, Switzerland 
Lance Liotta, George Mason University, VA, USA 
Stefania Mondello, University of Messina, Messina, Italy
Kazuyuki Nakamura, Yamaguchi University School of Medicine, Japan 
Edouard Nice, Monash University, Australia 
Gil Omenn, University of Michigan, IL, USA 
Andrew Ottens, Virginia Commonwealth University, VA, USA 
Emanuel Petricoin III, George Mason University, VA, USA
Wei-Jun Qian, Pacific Northwest National Laboratory, Richland, WA, USA 
Om Singh, The Johns Hopkins School of Medicine, MD, USA 
Gary Smejkal,  Hubbard Center for Genome Studies, University of New Hampshire, Durham, NH, USA 
Christopher Southan, IUPHAR Database, TW2Informatics, Sweden 
Visith Thongboonkerd, Mahidol University, Thailand
Rui Vitorino, University of Aveiro, Portugal
Kui Wang, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
Tesshi Yamada, National Cancer Center Research Institute, Japan
Petra Zürbig, mosaiques diagnostics GmbH, Hannover, Germany